10-Q Filing

Dominari Holdings Inc. CIK: 12239 Q2 2022

Filing Information

Form Type	10-Q
Accession Number	`0001213900-22-047493`
Period End Date	20220630
Filing Date	20220812
Fiscal Year	2022
Fiscal Period	Q2
XBRL Instance	f10q0622_aikidopharma_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 68 Income Statement 68 Cash Flow Statement 80 Stockholders Equity 35

Balance Sheet 68 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`RestrictedCashCurrent`	$38.79M	USD	Point-in-time
Cash and cash equivalents	`RestrictedCashCurrent`	$65.56M	USD	Point-in-time
Marketable securities	`MarketableSecurityCurrent`	$9.78M	USD	Point-in-time
Marketable securities	`MarketableSecurityCurrent`	$11.43M	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$442.00K	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$196.00K	USD	Point-in-time
Short-term investments at fair value	`ShortTermInvestments`	$2.27M	USD	Point-in-time
Short-term investments at fair value	`ShortTermInvestments`	$104.00K	USD	Point-in-time
Notes receivable at fair value	`NotesReceivableRelatedPartiesCurrent`	$6.98M	USD	Point-in-time
Notes receivable at fair value	`NotesReceivableRelatedPartiesCurrent`	$8.50M	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Deposits	`DepositsAssetsCurrent`	$4.20M	USD	Point-in-time
Deposits	`DepositsAssetsCurrent`	$4.19M	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$90.89M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$61.56M	USD	Point-in-time
Convertible note receivable at fair value	`NotesReceivableRelatedPartiesNoncurrent`	-	USD	Point-in-time
Convertible note receivable at fair value	`NotesReceivableRelatedPartiesNoncurrent`	$2.15M	USD	Point-in-time
Notes receivable at fair value	`NotesReceivableRelatedParties`	-	USD	Point-in-time
Notes receivable at fair value	`NotesReceivableRelatedParties`	$1.10M	USD	Point-in-time
Investments	`Investments`	$9.46M	USD	Point-in-time
Investments	`Investments`	$25.48M	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Security deposit	`SecurityDeposit`	$155.00K	USD	Point-in-time
Security deposit	`SecurityDeposit`	$155.00K	USD	Point-in-time
Total assets	`Assets`	$88.30M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Total assets	`Assets`	$102.66M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	5.28M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	5.25M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	5.28M	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$381.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	4.95M	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$142.00K	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockShares`	242,902.00	shares	Point-in-time
Treasury stock, at cost	`TreasuryStockShares`	0.00	shares	Point-in-time
Accrued salaries and benefits	`EmployeeRelatedLiabilitiesCurrent`	$687.00K	USD	Point-in-time
Accrued salaries and benefits	`EmployeeRelatedLiabilitiesCurrent`	$680.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$829.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.06M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.06M	USD	Point-in-time
Total liabilities	`Liabilities`	$829.00K	USD	Point-in-time
Preferred stock, $.0001 par value, 50,000,000 Authorized	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.0001 par value, 50,000,000 Authorized	`PreferredStockValue`	-	USD	Point-in-time
Series D: 5,000,000 shares designated; 3,825 shares issued and outstanding at June 30, 2022 and December 31, 2021; liquidation value of $0.0001 per share	`PreferredStockValueOne`	-	USD	Point-in-time
Series D: 5,000,000 shares designated; 3,825 shares issued and outstanding at June 30, 2022 and December 31, 2021; liquidation value of $0.0001 per share	`PreferredStockValueOne`	-	USD	Point-in-time
Series D-1: 5,000,000 shares designated; 834 shares issued and outstanding at June 30, 2022 and December 31, 2021; liquidation value of $0.0001 per share	`PreferredStockValueTwo`	-	USD	Point-in-time
Series D-1: 5,000,000 shares designated; 834 shares issued and outstanding at June 30, 2022 and December 31, 2021; liquidation value of $0.0001 per share	`PreferredStockValueTwo`	-	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 5,246,852 and 5,275,329 shares issued at June 30, 2022 and December 31, 2021, respectively; 4,953,950 and 5,275,329 shares outstanding at June 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 5,246,852 and 5,275,329 shares issued at June 30, 2022 and December 31, 2021, respectively; 4,953,950 and 5,275,329 shares outstanding at June 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$261.60M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$265.63M	USD	Point-in-time
Treasury stock, at cost, 242,902 and 0 shares at June 30, 2022 and December 31, 2021, respectively	`TreasuryStockValue`	$264.00K	USD	Point-in-time
Treasury stock, at cost, 242,902 and 0 shares at June 30, 2022 and December 31, 2021, respectively	`TreasuryStockValue`	$1.75M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-172.39M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-163.77M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$103.08M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$104.37M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$87.47M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$101.59M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$29.62M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$95.05M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$88.30M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$102.66M	USD	Point-in-time

Income Statement 68 line items

Line Item	Tag	Value	Unit	Period
Basic and Diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-2.42	USD	2 Qtrs
Basic and Diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.26	USD	1 Quarter
Basic and Diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-1.18	USD	1 Quarter
Basic and Diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-1.20	USD	2 Qtrs
Basic and Diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.25M	shares	2 Qtrs
General and administrative	`SellingGeneralAndAdministrativeExpense`	$2.26M	USD	1 Quarter
Basic and Diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.25M	shares	1 Quarter
General and administrative	`SellingGeneralAndAdministrativeExpense`	$2.34M	USD	1 Quarter
Basic and Diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	4.41M	shares	2 Qtrs
Basic and Diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.27M	shares	1 Quarter
General and administrative	`SellingGeneralAndAdministrativeExpense`	$4.05M	USD	2 Qtrs
General and administrative	`SellingGeneralAndAdministrativeExpense`	$3.56M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.05M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$36.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$325.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$397.00K	USD	2 Qtrs
Research and development - license acquired	`ResearchAndDevelopmentLicenseAcquired`	-	USD	1 Quarter
Research and development - license acquired	`ResearchAndDevelopmentLicenseAcquired`	$1.12M	USD	2 Qtrs
Research and development - license acquired	`ResearchAndDevelopmentLicenseAcquired`	$91.00K	USD	1 Quarter
Research and development - license acquired	`ResearchAndDevelopmentLicenseAcquired`	-	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$6.10M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$2.30M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$5.08M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$2.76M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-6.10M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-5.08M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-2.76M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-2.30M	USD	1 Quarter
Other income	`OtherIncome`	-	USD	1 Quarter
Other income	`OtherIncome`	$135.00K	USD	2 Qtrs
Other income	`OtherIncome`	-	USD	1 Quarter
Other income	`OtherIncome`	$64.00K	USD	2 Qtrs
Interest income	`InterestIncomeExpenseNet`	$220.00K	USD	1 Quarter
Interest income	`InterestIncomeExpenseNet`	$67.00K	USD	2 Qtrs
Interest income	`InterestIncomeExpenseNet`	$40.00K	USD	1 Quarter
Interest income	`InterestIncomeExpenseNet`	$399.00K	USD	2 Qtrs
(Loss) gain on marketable securities	`MarketableSecuritiesGainLoss`	$459.00K	USD	2 Qtrs
(Loss) gain on marketable securities	`MarketableSecuritiesGainLoss`	$-2.74M	USD	2 Qtrs
(Loss) gain on marketable securities	`MarketableSecuritiesGainLoss`	$1.80M	USD	1 Quarter
(Loss) gain on marketable securities	`MarketableSecuritiesGainLoss`	$-2.24M	USD	1 Quarter
Change in fair value of investment	`GainLossOnInvestments`	$-431.00K	USD	1 Quarter
Change in fair value of investment	`GainLossOnInvestments`	$-238.00K	USD	2 Qtrs
Change in fair value of investment	`GainLossOnInvestments`	$-898.00K	USD	2 Qtrs
Change in fair value of investment	`GainLossOnInvestments`	$-760.00K	USD	1 Quarter
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$-237.00K	USD	2 Qtrs
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$-2.51M	USD	2 Qtrs
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$-2.78M	USD	1 Quarter
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$1.41M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.61M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-5.31M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-5.08M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.35M	USD	1 Quarter
Deemed dividends related to Series O and Series P Redeemable Convertible Preferred Stock	`PreferredStockDividendsAndOtherAdjustments`	-	USD	1 Quarter
Deemed dividends related to Series O and Series P Redeemable Convertible Preferred Stock	`PreferredStockDividendsAndOtherAdjustments`	-	USD	2 Qtrs
Deemed dividends related to Series O and Series P Redeemable Convertible Preferred Stock	`PreferredStockDividendsAndOtherAdjustments`	$4.11M	USD	2 Qtrs
Deemed dividends related to Series O and Series P Redeemable Convertible Preferred Stock	`PreferredStockDividendsAndOtherAdjustments`	$1.10M	USD	1 Quarter
Net Loss Attributable to Common Shareholders	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$-5.31M	USD	2 Qtrs
Net Loss Attributable to Common Shareholders	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$-12.72M	USD	2 Qtrs
Net Loss Attributable to Common Shareholders	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$-6.18M	USD	1 Quarter
Net Loss Attributable to Common Shareholders	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$-1.35M	USD	1 Quarter
Basic and Diluted (in Dollars per share)	`EarningsPerShareBasic`	$-2.42	USD	2 Qtrs
Basic and Diluted (in Dollars per share)	`EarningsPerShareBasic`	$-1.18	USD	1 Quarter
Basic and Diluted (in Dollars per share)	`EarningsPerShareBasic`	$-1.20	USD	2 Qtrs
Basic and Diluted (in Dollars per share)	`EarningsPerShareBasic`	$-0.26	USD	1 Quarter
Basic and Diluted (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	4.41M	shares	2 Qtrs
Basic and Diluted (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	5.25M	shares	1 Quarter
Basic and Diluted (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	5.25M	shares	2 Qtrs
Basic and Diluted (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	5.27M	shares	1 Quarter

Cash Flow Statement 80 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-8.61M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-5.31M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-5.08M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.35M	USD	1 Quarter
Change in fair value of short-term investment	`ChangeInFairValueOfInvestments`	$898.00K	USD	2 Qtrs
Change in fair value of short-term investment	`ChangeInFairValueOfInvestments`	$1.65M	USD	2 Qtrs
Change in fair value of long-term investment	`ChangeInFairValueOfLongtermInvestment`	$-1.41M	USD	2 Qtrs
Change in fair value of long-term investment	`ChangeInFairValueOfLongtermInvestment`	-	USD	2 Qtrs
Research and development-acquired license, expensed	`ResearchAndDevelopmentacquiredLicenseExpensed`	$1.12M	USD	2 Qtrs
Research and development-acquired license, expensed	`ResearchAndDevelopmentacquiredLicenseExpensed`	-	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$105.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$175.00K	USD	2 Qtrs
Realized loss (gain) on marketable securities	`MarketableSecuritiesRealizedGainLoss`	$1.08M	USD	2 Qtrs
Realized loss (gain) on marketable securities	`MarketableSecuritiesRealizedGainLoss`	$-568.00K	USD	2 Qtrs
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-2.30M	USD	2 Qtrs
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-1.40M	USD	2 Qtrs
Realized gain on sale of digital currencies	`GainLossOnSaleOfOtherAssets`	-	USD	2 Qtrs
Realized gain on sale of digital currencies	`GainLossOnSaleOfOtherAssets`	-	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-153.00K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-39.00K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-248.00K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-239.00K	USD	2 Qtrs
Accrued salaries and benefits	`IncreaseDecreaseInAccruedSalaries`	$7.00K	USD	2 Qtrs
Accrued salaries and benefits	`IncreaseDecreaseInAccruedSalaries`	$423.00K	USD	2 Qtrs
Interest receivable on convertible note	`IncreaseDecreaseInNotesReceivables`	$399.00K	USD	2 Qtrs
Interest receivable on convertible note	`IncreaseDecreaseInNotesReceivables`	$67.00K	USD	2 Qtrs
Deposits	`IncreaseDecreaseInSecurityDeposits`	-	USD	2 Qtrs
Deposits	`IncreaseDecreaseInSecurityDeposits`	$8.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.66M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.87M	USD	2 Qtrs
Purchase of marketable securities	`PurchaseOfMarketableSecurities`	$27.46M	USD	2 Qtrs
Purchase of marketable securities	`PurchaseOfMarketableSecurities`	$86.50M	USD	2 Qtrs
Sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$28.27M	USD	2 Qtrs
Sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$23.16M	USD	2 Qtrs
Proceeds from sale of digital currencies	`ProceedsFromSaleOfDigitalCurrencies`	-	USD	2 Qtrs
Proceeds from sale of digital currencies	`ProceedsFromSaleOfDigitalCurrencies`	$93.00K	USD	2 Qtrs
Proceeds from promissory note receivable interest received	`ProceedsFromSaleAndCollectionOfNotesReceivable`	$22.00K	USD	2 Qtrs
Proceeds from promissory note receivable interest received	`ProceedsFromSaleAndCollectionOfNotesReceivable`	-	USD	2 Qtrs
Funds to deposit accounts, net	`ProceedFromFundsToDepositAccountsNet`	-	USD	2 Qtrs
Funds to deposit accounts, net	`ProceedFromFundsToDepositAccountsNet`	$-4.48M	USD	2 Qtrs
Purchase of short-term and long-term investments	`PaymentsToAcquireInvestments`	$14.61M	USD	2 Qtrs
Purchase of short-term and long-term investments	`PaymentsToAcquireInvestments`	-	USD	2 Qtrs
Purchase of research and development licenses	`PaymentsToAcquireInProcessResearchAndDevelopment`	-	USD	2 Qtrs
Purchase of research and development licenses	`PaymentsToAcquireInProcessResearchAndDevelopment`	$594.00K	USD	2 Qtrs
Purchase of short-term and long-term promissory notes	`PurchaseOfShorttermAndLongtermPromissoryNotes`	-	USD	2 Qtrs
Purchase of short-term and long-term promissory notes	`PurchaseOfShorttermAndLongtermPromissoryNotes`	$1.60M	USD	2 Qtrs
Purchase of convertible note	`PurchaseOfConvertibleNote`	$2.00M	USD	2 Qtrs
Purchase of convertible note	`PurchaseOfConvertibleNote`	-	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-15.28M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-70.41M	USD	2 Qtrs
Proceeds from issuance of common stock and warrants, net of offering cost	`ProceedsFromIssuanceCommonStockAndWarrantsNetOfOfferingCost`	-	USD	2 Qtrs
Proceeds from issuance of common stock and warrants, net of offering cost	`ProceedsFromIssuanceCommonStockAndWarrantsNetOfOfferingCost`	$77.99M	USD	2 Qtrs
Proceeds from issuance of Series O and Series P Redeemable Convertible Preferred Stock, net of discount and offering cost	`ProceedsFromIssuanceOfCommonStock`	$17.89M	USD	2 Qtrs
Proceeds from issuance of Series O and Series P Redeemable Convertible Preferred Stock, net of discount and offering cost	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$84.00K	USD	2 Qtrs
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	2 Qtrs
Payment for fractional shares	`PaymentForFractionalShares`	-	USD	2 Qtrs
Payment for fractional shares	`PaymentForFractionalShares`	$26.00K	USD	2 Qtrs
Redemption of Series O and Series P Redeemable Convertible Preferred Stock	`ProceedsFromIssuanceOfConvertiblePreferredStock`	$-22.00M	USD	2 Qtrs
Redemption of Series O and Series P Redeemable Convertible Preferred Stock	`ProceedsFromIssuanceOfConvertiblePreferredStock`	-	USD	2 Qtrs
Purchase of treasury stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	2 Qtrs
Purchase of treasury stock	`PaymentsForRepurchaseOfCommonStock`	$1.49M	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-5.62M	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$78.07M	USD	2 Qtrs
Net (decrease) increase in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$5.00M	USD	2 Qtrs
Net (decrease) increase in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-26.77M	USD	2 Qtrs
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.71M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$65.56M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$38.79M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.72M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.71M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$65.56M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$38.79M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.72M	USD	Point-in-time
Transfer from short-term investment to marketable securities	`TransferFromShorttermInvestmentToMarketableSecurities`	-	USD	2 Qtrs
Transfer from short-term investment to marketable securities	`TransferFromShorttermInvestmentToMarketableSecurities`	$1.48M	USD	2 Qtrs
Reclassify from convertible note receivable to notes receivable at fair value	`ReclassifyFromConvertibleNoteReceivableToNotesReceivableAtFairValue`	-	USD	2 Qtrs
Reclassify from convertible note receivable to notes receivable at fair value	`ReclassifyFromConvertibleNoteReceivableToNotesReceivableAtFairValue`	$2.15M	USD	2 Qtrs
Promissory convertible note receivable conversion into common shares	`PromissoryConvertibleNoteReceivableConversionIntoCommonShares`	-	USD	2 Qtrs
Promissory convertible note receivable conversion into common shares	`PromissoryConvertibleNoteReceivableConversionIntoCommonShares`	$1.51M	USD	2 Qtrs

Stockholders Equity 35 line items

Line Item	Tag	Value	Unit	Period
Net of offering costs	`WarrantNetOfferingCosts`	$8.26M	USD	2 Qtrs
Balance	`StockholdersEquity`	$103.08M	USD	Point-in-time
Balance	`StockholdersEquity`	$104.37M	USD	Point-in-time
Balance	`StockholdersEquity`	$87.47M	USD	Point-in-time
Balance	`StockholdersEquity`	$101.59M	USD	Point-in-time
Balance	`StockholdersEquity`	$29.62M	USD	Point-in-time
Balance	`StockholdersEquity`	$95.05M	USD	Point-in-time
Issuance of Series O redeemable convertible preferred stock for cash	`StockIssuedDuringPeriodValueNewIssues`	-	USD	2 Qtrs
Issuance of Series P redeemable convertible preferred stock for cash	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	-	USD	2 Qtrs
Cost on issuance of Series O and Series P Redeemable Convertible Preferred Stock	`StockIssuedDuringPeriodValueOther`	$10.48M	USD	Point-in-time
Cost on issuance of Series O and Series P Redeemable Convertible Preferred Stock	`StockIssuedDuringPeriodValueOther`	-	USD	2 Qtrs
Deemed dividends related to Series O and Series P Redeemable Convertible Preferred Stock	`StockIssuedDuringPeriodValueConversionOfUnits`	$-4.11M	USD	2 Qtrs
Deemed dividends related to Series O and Series P Redeemable Convertible Preferred Stock	`StockIssuedDuringPeriodValueConversionOfUnits`	$-1.10M	USD	1 Quarter
Repurchase of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$1.49M	USD	1 Quarter
Repurchase of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$1.49M	USD	2 Qtrs
Issuance of common stock and warrants (net of offering costs of $8,260)	`StockIssuedDuringPeriodValueOfCommonStockAndWarrants`	$77.99M	USD	2 Qtrs
Exercise of warrants	`StockIssuedDuringPeriodValueStockOptionsExercised`	$84.00K	USD	2 Qtrs
Issuance of common stock for research and development license acquired	`StockIssuedDuringPeriodValueIssuedForResearchAndDevelopmentLicenseAcquired`	$531.00K	USD	2 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition`	$105.00K	USD	2 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition`	$105.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition`	$63.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition`	$175.00K	USD	2 Qtrs
Cancellation of common stock related to investment in CBM	`DistributionOfHothCommonStock`	-	USD	2 Qtrs
Fractional shares adjusted for reverse split	`AdjustmentsToAdditionalPaidInCapitalStockSplit`	$-26.00K	USD	2 Qtrs
Fractional shares adjusted for reverse split	`AdjustmentsToAdditionalPaidInCapitalStockSplit`	$-26.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.61M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-5.31M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-5.08M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.35M	USD	1 Quarter
Balance	`StockholdersEquity`	$103.08M	USD	Point-in-time
Balance	`StockholdersEquity`	$104.37M	USD	Point-in-time
Balance	`StockholdersEquity`	$87.47M	USD	Point-in-time
Balance	`StockholdersEquity`	$101.59M	USD	Point-in-time
Balance	`StockholdersEquity`	$29.62M	USD	Point-in-time
Balance	`StockholdersEquity`	$95.05M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.